The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)
Filter results
| Date | Title | Content | |
|---|---|---|---|
| 2/04/2020 | On business and financial situation | ROVI informs on the impact of Covid‑19 on the company’s activities | |
| 2/04/2020 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the first quarter of 2020 | |
| 26/02/2020 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors | |
| 26/02/2020 | Information on P&L | ROVI releases the full year 2019 results presentation | |
| 26/02/2020 | Annual Corporate Governance Report | ROVI releases the 2019 Annual Corporate Governance Report | |
| 26/02/2020 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | |
| 26/02/2020 | Information on P&L | ROVI releases the press release related to the full year 2019 financial results | |
| 31/01/2020 | R&D: new licenses, patents and registered trademarks | The Company informs about the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union | |
| 8/01/2020 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the fourth quarter of 2019 |